DNAJC5 and Plasmodium falciparum malaria: CSP is the leading antigen target for sub-unit vaccines against malaria, and is the antigenic component of the virus-like particle RTS,S which is the most advanced human vaccine candidate against Plasmodium falciparum malaria.